Clinical Trials · NCT02503605

Biosimilar Versus Urinary Gonadotropins

UnknownPhase 4Gonadorelin (Unclear)
Phase
Phase 4
Recruitment status
Unknown
Sponsor
IVI Madrid
Enrollment
130
Start date
Oct 2015
Locations
1 site, Spain
Primary endpoint
Number of metaphase II oocytes
View Gonadorelin compound reference